Ole-Chr. Rutherford (@ocrutherford) header
Ole-Chr. Rutherford (@ocrutherford) profile picture

❤️doc | Researcher, focusing on atrial fibrillation, cardiovascular pharmacology, epidemiology

Joined March 2013
I agree, same in our HFU. Sac/val is rarely used.
1
32
I think the real question is why did they not compare sac/val against ramipril 10mg/d, ACE inhibitors are still recommended as first choice in the guidelines, not ARBs.
1
1
99
«The only positive trials with sacubutril/Vallarta’s other than PARADIGM are near worthless BNP-trials». One of the most important voices in cardiology worldwide. Check out the podcast!! @drjohnm
An HRS meeting recap, Impella failure, sacubitril/valsartan, the purpose of trials, and a major breakthrough in evidence generation are the topics discussed by @drjohnm in this week's podcast. ms.spr.ly/6011gdBgz
2
3
1
9
4,506
Ole-Chr. Rutherford retweeted
this may truly open a new era in prevention…
1
1
Emerging role for #SGLT2 inhibitors in mitigating the risk of hyperkalaemia in heart failure academic.oup.com/eurheartj/a… @ehj_ed @rladeiraslopes #EHJ #ESCYoung
36
2
105
Ole-Chr. Rutherford retweeted
Annabel's Master’s research focuses on discovering the function of a novel Autism (ASD) risk gene. "While the Scherer lab has discovered many ASD risk genes, the one I am studying is unique in that it encodes a long noncoding RNA (lncRNA) instead of a protein." #WomenInScience
1
4
8
In a nationwide registry - digoxin: lower mortality/morbidity in #HFrEF with AF, but higher mortality/morbidity in HF without AF academic.oup.com/ehjcvp/adva… #EHJPharmacotherapy #cardiotwitter @AgewallStefan @GianluSava
53
7
130
Ole-Chr. Rutherford retweeted
360 patients aged 65-80 years old without atrial fibrillation or other indications for anticoagulation will be randomized 1:1 to receive either DOAC monotherapy (intervention) or acetylsalicylic acid (standard-of-care) after successful TAVI
3
3
From @jaccjournals jacc.org/doi/abs/10.1016/j.j… I agree with @drjohnm : «any future trial of high bleeding-risk patients should include a half-dose DOAC alone, because if this cocktail worked well with a foreign body in the left atrium, it’s possible it could work even better alone»
1
Ole-Chr. Rutherford retweeted
Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention? academic.oup.com/eurheartj/a… @ESC_Journals #EHJ #cardiotwitter
3
25
2
58
Ole-Chr. Rutherford retweeted
Excited to present our cost evaluation analysis on the low-risk assessment with the ESC 0/1h algorithm in emergency primary care vs hospital ED at the #ESCCongress2021 on behalf of the OUT-ACS group @dan_atar @sighalvo @john_munkhaugen @TorbWis
4
1
14
Ole-Chr. Rutherford retweeted
Those at low risk for COVID-19 should be allowed to weigh their vaccine decisions without anyone being tarred as an antivaxxer. ms.spr.ly/6012nnzPn via @drjohnm #AgainstAbsolutism #Myocarditis
1
7
10
Ole-Chr. Rutherford retweeted
🚀New impact factors 2021😱 - EHJ: 29.9 - Circulation: 29.7 - JACC: 24.1 - JACC CVI: 14.8 - Circ CVI: 7.8 - EHJCVI: 6.8 - JCMR: 5,4 - JMRI: 4.8 - European Radiology: 5.3 - Radiology: 11.2 - ACVD: 2.3 - Frontiers CV Medicine: 6.1 - Hypertension: 10.2 📲 researchgate.net/profile/Ist…
6
19
7
92
Thank you @sighalvo
Happy to share this New paper from Norwegian registries on Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation heart.bmj.com/content/early/…. CONGRATULATIONS to Ole-Christian Rutherford!
Ole-Chr. Rutherford retweeted
Happy to share this New paper from Norwegian registries on Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation heart.bmj.com/content/early/…. CONGRATULATIONS to Ole-Christian Rutherford!